Identification of a novel ‘aggregation‐prone’/‘amyloidogenic determinant’ peptide in the sequence of the highly amyloidogenic human calcitonin

TAMLGT peptide and TAMLGT peptide bind by electron microscopy (View interaction)

[1]  Scott J. Hultgren,et al.  Role of Escherichia coli Curli Operons in Directing Amyloid Fiber Formation , 2002, Science.

[2]  E. D. Williams,et al.  Histogenesis of medullary carcinoma of the thyroid , 1966, Journal of clinical pathology.

[3]  D. Copp,et al.  Calcitonin—a Hormone from the Parathyroid which Lowers the Calcium-level of the Blood , 1962, Nature.

[4]  Meital Reches,et al.  Amyloid Fibril Formation by Pentapeptide and Tetrapeptide Fragments of Human Calcitonin* , 2002, The Journal of Biological Chemistry.

[5]  E. Atkins,et al.  "Cross-beta" conformation in proteins. , 1968, Journal of molecular biology.

[6]  P. Altmann,et al.  The management of severe hypercalcaemia. , 1987, Postgraduate medical journal.

[7]  S. Cai,et al.  Identification of beta-turn and random coil amide III infrared bands for secondary structure estimation of proteins. , 1999, Biophysical chemistry.

[8]  G. Glenner,et al.  THE RELATION OF THE PROPERTIES OF CONGO RED-STAINED AMYLOID FIBRILS TO THE β-CONFORMATION , 1972, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  S. Hamodrakas,et al.  Amyloid fibrillogenesis of silkmoth chorion protein peptide-analogues via a liquid-crystalline intermediate phase. , 2004, Journal of structural biology.

[10]  A. Donald,et al.  Optical microscopy of growing insulin amyloid spherulites on surfaces in vitro. , 2006, Biophysical journal.

[11]  V. K. Bajpai,et al.  Unraveling the amyloid associated with human medullary thyroid carcinoma. , 2004, Endocrinology.

[12]  Atanas V Koulov,et al.  Functional amyloid--from bacteria to humans. , 2007, Trends in biochemical sciences.

[13]  P. Fraser,et al.  Human pro-islet amyloid polypeptide (ProIAPP(1-48)) forms amyloid fibrils and amyloid spherulites in vitro. , 2010, Journal of inorganic biochemistry.

[14]  H. Mantsch,et al.  The use and misuse of FTIR spectroscopy in the determination of protein structure. , 1995, Critical reviews in biochemistry and molecular biology.

[15]  E. Gazit,et al.  Converting the Highly Amyloidogenic Human Calcitonin into a Powerful Fibril Inhibitor by Three-dimensional Structure Homology with a Non-amyloidogenic Analogue* , 2010, The Journal of Biological Chemistry.

[16]  C. Blake,et al.  The structure of amyloid fibrils by electron microscopy and X-ray diffraction. , 1997, Advances in protein chemistry.

[17]  H. Mantsch,et al.  Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment. , 1993, Biochemistry.

[18]  Robert Gurny,et al.  Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  A. Kapurniotu,et al.  Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt. , 2002, European journal of biochemistry.

[20]  A. Drake,et al.  The structure and mechanism of formation of human calcitonin fibrils. , 1993, The Journal of biological chemistry.

[21]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[22]  K. Mantsopoulos,et al.  Intranasal complications in women with osteoporosis under treatment with nasal calcitonin spray: case reports and review of the literature. , 2008, Auris, nasus, larynx.

[23]  C. Dobson,et al.  Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Massry,et al.  The clinical physiology of calcium homeostasis, parathyroid hormone an, and calcitonin. I. , 1971, California medicine.

[25]  G. Vriend,et al.  Amyloids protect the silkmoth oocyte and embryo , 2000, FEBS letters.

[26]  Daniel Louër,et al.  Powder pattern indexing with the dichotomy method , 2004 .

[27]  A. Miller,et al.  The formation of spherulites by amyloid fibrils of bovine insulin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Haris,et al.  The conformational analysis of peptides using fourier transform IR spectroscopy , 1995, Biopolymers.

[29]  A. Savitzky,et al.  Smoothing and Differentiation of Data by Simplified Least Squares Procedures. , 1964 .

[30]  J. Hazard,et al.  Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. , 1959, The Journal of clinical endocrinology and metabolism.

[31]  U Aebi,et al.  Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. , 1995, Journal of structural biology.

[32]  J. Bandekar,et al.  Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. , 1986, Advances in protein chemistry.

[33]  E. Atkins,et al.  “Cross-β” conformation in proteins☆ , 1968 .

[34]  Cheri Logan,et al.  Treatment of Paget's Disease of Bone with Salmon Calcitonin Nasal Spray , 1988, Journal of the American Geriatrics Society.

[35]  A. Donald,et al.  Spherulites of amyloid-beta42 in vitro and in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[36]  E. Goormaghtigh,et al.  The different molar absorptivities of the secondary structure types in the amide I region: an attenuated total reflection infrared study on globular proteins. , 1996, Analytical biochemistry.

[37]  A. Cohen,et al.  Structure of Amyloid Fibrils after Negative Staining and High-resolution Electron Microscopy , 1965, Nature.

[38]  M. Fändrich.  On the structural definition of amyloid fibrils and other polypeptide aggregates , 2007, Cellular and Molecular Life Sciences.